Company news
Therma Bright Inc. news in 2025
Therma Bright Inc.'s news releases, calls and decks from 2025, newest first.
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
December 18, 2025
Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors
October 10, 2025
Therma Bright Expands Relationship with Distribution Partner Gen-X Med for Venowave(TM) Sales
September 24, 2025
Therma Bright Proposes to Amend Certain Warrants
August 28, 2025
Therma Bright Announces Share Consolidation
July 3, 2025
Therma Bright Inc. Announces Share Consolidation
June 11, 2025
Therma Bright Proposes to Amend Certain Warrants and Negotiates Debt Settlements
June 5, 2025
Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin
May 8, 2025
Therma Bright Secures New Customer Initial Purchase Order, Signaling Market Confidence
April 24, 2025
Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes
April 16, 2025
Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC
March 13, 2025
Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board
February 4, 2025
Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN
January 21, 2025
Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio
January 13, 2025
Therma Bright Announces Shares for Debt Issuance
January 9, 2025